What We’re Reading: VA Nominee and Retirement Choice; Mega Deals and PCPs; Novartis Buys Gene Therapy Firm – AJMC.com Managed Markets Network
|
What We’re Reading: VA Nominee and Retirement Choice; Mega Deals and PCPs; Novartis Buys Gene Therapy Firm
AJMC.com Managed Markets Network Ronny L. Jackson, MD, would give up $1 million in retirement income to head the Department of Veterans Affairs and work in the Trump administration; mega healthcare deals endanger independent practices of primary care providers; Novartis is buying a … |
|
US regulators clarify stance on CRISPR‘d food
BioNews CRISPR greens may soon be served in the USA: the US Secretary of Agriculture, Sonny Perdue clarified the stance of the US Department of Agriculture (USDA) on crops that have been genome edited using the tool. Such plants can be developed and sold free … |
Immuno-Oncology News |
Pfizer and Allogene Agree to Collaborate on Developing Donor-derived CAR T-cell Therapies
Immuno-Oncology News Pfizer and Allogene Therapeutics have entered into a contribution agreement for Pfizer’s portfolio of assets related to donor-derived chimeric antigen receptor T-cell (CAR T) therapy, a kind of cell therapy directed at blood cancers and solid tumors … Allogene Therapeutics Completes Agreement for Pfizer’s Allogeneic CAR T Immuno-oncology PortfolioDigital Journal |
Business Wire (press release) |
Pfizer and Allogene Agree to Collaborate on Developing Donor-derived CAR T-cell Therapies
Immuno-Oncology News Pfizer and Allogene Therapeutics have entered into a contribution agreement for Pfizer’s portfolio of assets related to donor-derived chimeric antigen receptor T-cell (CAR T) therapy, a kind of cell therapy directed at blood cancers and solid tumors … Allogene Therapeutics Completes Agreement for Pfizer’s Allogeneic CAR T Immuno-oncology PortfolioBusiness Wire (press release) |